. MK886 Ameliorates Alzheimer's Disease by Activating the PRKCI/AKT Signaling Pathway. Eur J Pharmacol. 2025 Feb 6;:177359. Epub 2025 Feb 6 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.